Profound Medical (u.s.) INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersFort Myers, FL
SAM.gov UEIPD1EC4ASBCG4
Profound Medical develops incision-free ablative therapies for prostate treatment, including the TULSA-PRO® system which uses transurethral ultrasound ablation guided by MRI to ablate prostate tissue. The company serves the urology and prostate cancer care market, offering customizable treatment planning with 360-degree targeting capability as an alternative to surgical approaches like radical prostatectomy.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Profound Medical (u.s.) INC. | Fort Myers | FL | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.